A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides

L P Sheets1

  • 1Bayer Corporation, Toxicology, Stilwell, KS, USA. larry.sheets.b@bayer.com

Neurotoxicology
|May 4, 2000
PubMed

Insights

Neonates are not more sensitive than adults to lower doses of organophosphorus (OP) and pyrethroid insecticides. Existing food residue limits adequately protect infants and children from these common pesticides.

Area of Science:

  • Environmental toxicology
  • Developmental toxicology
  • Pesticide risk assessment

Background:

  • Organophosphorus (OP) and pyrethroid insecticides are widely used.
  • Neonates may exhibit greater sensitivity to these pesticides than adults, particularly at lethal doses.
  • Risk assessment for food-use pesticides requires understanding sensitivity at environmentally relevant exposure levels.

Purpose of the Study:

  • To determine if neonates are more sensitive than adults to lower, environmentally relevant doses of OP and pyrethroid insecticides.
  • To inform pesticide residue limit (tolerance) setting for infant and child protection.
  • To evaluate the need for additional uncertainty factors in risk assessments.

Main Methods:

  • Multi-generation reproduction studies with rats exposed to OP insecticides (coumaphos, fenamiphos, tribufos, trichlorfon, oxydemeton-methyl) via diet.
  • Acute gavage studies with rats exposed to pyrethroids (cismethrin, permethrin, deltamethrin, cypermethrin) at lethal and low doses.
  • Cholinesterase (ChE) inhibition measured as a key indicator of OP exposure.
  • Dose-response assessments comparing adult and pup sensitivity.

Main Results:

  • Cholinesterase inhibition was the most sensitive measure for OP insecticides; pup ChE inhibition was less than adult inhibition at equivalent dietary levels.
  • For Type I pyrethroids, no increased sensitivity was observed in pups compared to adults.
  • For Type II pyrethroids, young rats showed greater sensitivity to lethal doses, attributed to immature detoxification systems, but not to lower doses.

Conclusions:

  • Young animals are not more sensitive than adults to lower exposure levels of OP and pyrethroid insecticides.
  • Existing food tolerances for these pesticides likely provide adequate protection for infants and children.
  • No additional uncertainty factor appears necessary for risk assessment based on these findings.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...